Insights on the global lactoferrin market to 2028

DUBLIN, November 25, 2021 /PRNewswire/ — The “Global Lactoferrin Market Size, Share & Trends Analysis Report by Function (Iron Absorption, Intestinal Flora Protection), by Application (Personal Care Products, Infant Formula), by Region (APAC, Europe) and the Segment Forecasts, 2021-2028″ report has been added to’s offer.

Logo for research and markets

The global market size of lactoferrin is expected to USD 411.8 million by 2028, with a revenue-based CAGR of 8.2% over the forecast period.

Increasing inclusion of lactoferrin in various product ranges, including infant formulas, nutritional supplements, dietetic foods, alcoholic beverages, sports nutrition and personal care and cosmetics, should bolster the lactoferrin market in the predicted time frame, which is attributed to strong health benefits.

Lactoferrin provides stimulating effects on the immune system, prevents cell damage caused by aging, promotes the cultivation of beneficial bacteria in the intestinal tract and regulates viruses, bacteria and fungi and is also a regulator of iron metabolism. Lactoferrin has been shown to be effective for treating hepatitis C infection by inhibiting the replication of the virus at the intracellular level. Therefore, the strong applicability of lactoferrin in the nutraceutical, pharmaceutical and personal care industries is expected to drive demand during the forecast period.

Human colostrum has the highest lactoferrin concentration, followed by breast milk and then bovine milk. It is also easily found in secretions of the human body, including nose, eyes, intestines and respiratory tract. Lactoferrin can be used as an amalgamation of specific strains of friendly bacteria. Together, they have been proven to boost the body’s immune function, warn white blood cells from harmful microbes, and stabilize colonies of gut-friendly bacteria. Commercially, lactoferrin is often integrated with probiotics to achieve this.

Asia-Pacific is expected to grow at a CAGR of over 7.5% over the forecast period. The lactoferrin market is expected to see a surge in demand as key market players continue to adopt strategies to enhance their presence in untapped economies of South East Asia. countries including: China, Japan, and Australia have experienced great awareness regarding the health benefits of lactoferrin, which is expected to bolster regional growth over the forecast period.

Highlights of the Lactoferrin Market Report:

  • In terms of features offered by lactoferrin, the iron absorption segment accounted for the largest market share at over 29.0% in terms of sales in 2019. This growth is expected to be supported by the increasing incidence of iron deficiency and related conditions such as anemia.

  • Lactoferrin helps limit acne growth due to its antioxidant properties. It helps fight free radicals formed by the natural oxidation process. These free radicals can damage cells and tissues and promote inflammation and acne. Such factors are expected to boost demand for personal care and cosmetic products

  • Increasing investment in research, new product development, expanding operations in developing countries, partnerships and collaborations with local players, and acquisition of small and medium-sized players are among the key operational strategies that key participants use to strengthen and maintain their market positions

Main topics covered:

Chapter 1. Methodology and scope

Chapter 2. Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights

Chapter 3. Lactoferrin Market Variables, Trends and Scope
3.1. Market Lineage Outlook
3.2. Lactoferrin Market Size and Growth Outlook, 2017 – 2028
3.3. Industry Value Chain Analysis
3.3.1. Major commodity trends
3.3.2. Manufacturing Trends/Technology Trends
3.3.3. List of top end users, by region
3.4. Trends in sales channels
3.5. Regulatory framework
3.6. Lactoferrin Market – Market Dynamics
3.6.1. Market Factor Analysis
3.6.2. Market Constraint Analysis
3.6.3. Industry Challenges
3.7. Business Environment Analysis: Lactoferrin Market
3.7.1. Sector Analysis – Porter’s Supplier Power Buyer Power: Substitution Threat Threat of newcomer Competitive Battle
3.7.2. PESTEL analysis Political landscape Environmental landscape Social landscape Technology landscape Economic landscape Legal landscape
3.7.3. Analysis of key deals and strategic alliances Joint Ventures Mergers & Acquisitions

Chapter 4. Lactoferrin Market: Function Estimates and Trend Analysis
4.1. Lactoferrin Market: Function Movement Analysis, 2020 & 2028
4.2. Iron absorption
4.2.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
4.3. Anti-inflammatory
4.3.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
4.4. Gut flora protection
4.4.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
4.5. antibacterial
4.5.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
4.6. Immune Cell Stimulation
4.6.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
4.7. antioxidant
4.7.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)

Chapter 5. Lactoferrin Market: Application Estimates and Trend Analysis
5.1. Lactoferrin Market: Application Movement Analysis, 2020 & 2028
5.2. Food and drink
5.2.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
5.3. infant formula
5.3.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
5.4. Sports and functional food
5.4.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
5.5. animal food
5.5.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
5.6. Medicines
5.6.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)
5.7. Personal care products
5.7.1. Market estimates and forecasts, 2017 – 2028 (tons) (USD thousand)

Chapter 6. Lactoferrin Market: Regional Estimates and Trend Analysis

Chapter 7. Lactoferrin Market: Competitive Analysis
7.1. Key global players, their initiatives and their impact on the market
7.2. Top business/competition categorization (key innovators, industry leaders, emerging players)
7.3. Supplier landscape
7.3.1. List of Major Distributors and Channel Partners
7.3.2. Main customers
7.3.3. Business Ranking, 2020
7.4. Public companies
7.4.1. Analysis of the company’s market position
7.4.2. Business Ranking, 2020
7.4.3. SWOT analysis
7.5. Private companies
7.5.1. List of Major Emerging Companies/Tech Disruptors/Innovators
7.5.2. geographical presence
7.5.3. Analysis of the company’s market position

Chapter 8. Company Profiles
8.1. Hilmar Cheese Company
8.1.1. Corporate overview
8.1.2. Financial performance
8.1.3. Product Benchmarking
8.1.4. Strategic initiatives
8.2. Pharming Group NV
8.2.1. Corporate overview
8.2.2. Financial performance
8.2.3. Product Benchmarking
8.2.4. Strategic initiatives
8.3. FrieslandCampina
8.3.1. Corporate overview
8.3.2. Financial performance
8.3.3. Product Benchmarking
8.3.4. Strategic initiatives
8.4. Synlait Milk Ltd
8.4.1. Corporate overview
8.4.2. Financial performance
8.4.3. Product Benchmarking
8.4.4. Strategic initiatives
8.5. Ingredia SA
8.5.1. Corporate overview
8.5.2. Financial performance
8.5.3. Product Benchmarking
8.5.4. Strategic initiatives
8.6. MP Biomedicals
8.6.1. Corporate overview
8.6.2. Financial performance
8.6.3. Product Benchmarking
8.6.4. Strategic initiatives
8.7. Tatura Milk Industries Ltd
8.7.1. Corporate overview
8.7.2. Financial performance
8.7.3. Product Benchmarking
8.7.4. Strategic initiatives
8.8. Glanbia PLC
8.8.1. Corporate overview
8.8.2. Financial performance
8.8.3. Product Benchmarking
8.8.4. Strategic initiatives
8.9. APS BioGroup
8.9.1. Corporate overview
8.9.2. Financial performance
8.9.3. Product Benchmarking
8.9.4. Strategic initiatives
8.10. ProHealth
8.10.1. Corporate overview
8.10.2. Financial performance
8.10.3. Product Benchmarking
8.10.4. Strategic initiatives
8.11. Fonterra Cooperative Group Ltd.
8.11.1. Corporate overview
8.11.2. Financial performance
8.11.3. Product Benchmarking
8.11.4. Strategic initiatives
8.12. Freshest brands
8.12.1. Corporate overview
8.12.2. Financial performance
8.12.3. Product Benchmarking
8.12.4. Strategic initiatives
8.13. InVitria
8.13.1. Corporate overview
8.13.2. Financial performance
8.13.3. Product Benchmarking
8.13.4. Strategic initiatives
8.14 Milei GmbH
8.14.1. Corporate overview
8.14.2. Financial performance
8.14.3. Product Benchmarking
8.14.4. Strategic initiatives
8.15. Ferrin-Tech LLC
8.15.1. Corporate overview
8.15.2. Financial performance
8.15.3. Product Benchmarking
8.15.4. Strategic initiatives

For more information on this report, please visit

Media contact:

Research and markets
Laura Wood, senior manager

For EST business hours, call +1-917-300-0470
For US/CAN Toll Free Call +1-800-526-8630
For GMT office hours, please call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716



View original content:—size-share–trends-analysis-report-301432168.html

SOURCE Research and markets

Leave a Comment